{"schema_version":"secwatch.filing_event.v1","accession":"0001062822-25-000005","form_type":"8-K","ticker":"LXRX","cik":"0001062822","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2025-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.842466+00:00","generated_at":"2026-05-28T07:43:00.818690+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lexicon Pharmaceuticals receives Nasdaq bid-price deficiency notice; 180 days to cure","bullets":["Nasdaq notified Lexicon on Jan 3, 2025 that bid price closed below $1 for 31 consecutive business days.","Company has until July 2, 2025 to regain compliance by closing at $1+ for 10 consecutive days.","If not cured, Lexicon may seek a second 180-day period if it meets other listing standards; reverse split considered.","Notice does not cause immediate delisting; company will monitor and evaluate options.","No assurance that compliance can be regained or maintained."],"urls":{"canonical":"https://secwatch.observer/filing/0001062822-25-000005","json":"https://secwatch.observer/filing/0001062822-25-000005.json","markdown":"https://secwatch.observer/filing/0001062822-25-000005.md","text":"https://secwatch.observer/filing/0001062822-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/0001062822-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/lxrx-20250103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T07:43:00.818690+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"79e499946dd8282160c438e21fc68c279621e314","claim":"LEXICON PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"January 3, 2025, we received a letter (the “Notice”) from the Listing Qualifications staff of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of our common stock for the last 31 c","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/0001062822-25-000005-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}